These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32955097)

  • 1. Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.
    Gupta T; Cowan HR; Strauss GP; Walker EF; Mittal VA
    Schizophr Bull; 2021 Jan; 47(1):54-63. PubMed ID: 32955097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.
    Chang WC; Strauss GP; Ahmed AO; Wong SCY; Chan JKN; Lee EHM; Chan SKW; Hui CLM; James SH; Chapman HC; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):386-394. PubMed ID: 32909606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.
    Strauss GP; Horan WP; Kirkpatrick B; Fischer BA; Keller WR; Miski P; Buchanan RW; Green MF; Carpenter WT
    J Psychiatr Res; 2013 Jun; 47(6):783-90. PubMed ID: 23453820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative symptom dimensions differentially impact on functioning in individuals at-risk for psychosis.
    Chang WC; Lee HC; Chan SI; Chiu SY; Lee HM; Chan KW; Wong MC; Chan KL; Yeung WS; Choy LW; Chong SY; Siu MW; Lo TL; Yan WC; Ng MK; Poon LT; Pang PF; Lam WC; Wong YC; Chung WS; Mo YM; Lui SY; Hui LM; Chen EYH
    Schizophr Res; 2018 Dec; 202():310-315. PubMed ID: 29935882
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis.
    Kimhy D; Gill KE; Brucato G; Vakhrusheva J; Arndt L; Gross JJ; Girgis RR
    Psychol Med; 2016 Oct; 46(14):2907-2918. PubMed ID: 27050714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.
    Strauss GP; Cohen AS
    Schizophr Bull; 2017 Jul; 43(4):712-719. PubMed ID: 28969356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.
    Guessoum SB; Le Strat Y; Dubertret C; Mallet J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109862. PubMed ID: 31927053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological Correlate of Emotion Regulation by Cognitive Reappraisal and Its Association With Psychotic Symptoms in Early Psychosis.
    Kim M; Hwang WJ; Park J; Kim T; Oh S; Kwon JS
    Schizophr Bull; 2021 Jan; 47(1):87-96. PubMed ID: 32609340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Negative Symptoms in Schizophrenia - an Overview].
    Klaus F; Kaiser S; Kirschner M
    Ther Umsch; 2018 Jun; 75(1):51-56. PubMed ID: 29909762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cluster analysis of negative symptoms identifies distinct negative symptom subgroups.
    Paul NB; Strauss GP; Woodyatt JJ; Paul MG; Keene JR; Allen DN
    Schizophr Res; 2022 Aug; 246():207-215. PubMed ID: 35809353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.
    Azis M; Strauss GP; Walker E; Revelle W; Zinbarg R; Mittal V
    Schizophr Bull; 2019 Sep; 45(5):1042-1050. PubMed ID: 30535399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latent class cluster analysis of symptom ratings identifies distinct subgroups within the clinical high risk for psychosis syndrome.
    Ryan AT; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Schizophr Res; 2018 Jul; 197():522-530. PubMed ID: 29279247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.
    Schlosser DA; Campellone TR; Biagianti B; Delucchi KL; Gard DE; Fulford D; Stuart BK; Fisher M; Loewy RL; Vinogradov S
    Schizophr Res; 2015 Dec; 169(1-3):204-208. PubMed ID: 26530628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
    Strauss GP; Macdonald KI; Ruiz I; Raugh IM; Bartolomeo LA; James SH
    Eur Arch Psychiatry Clin Neurosci; 2022 Feb; 272(1):17-27. PubMed ID: 33881621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship between Negative Symptoms and Both Emotion Management and Non-social Cognition in Schizophrenia Spectrum Disorders.
    Yolland COB; Carruthers SP; Toh WL; Neill E; Sumner PJ; Thomas EHX; Tan EJ; Gurvich C; Phillipou A; Van Rheenen TE; Rossell SL
    J Int Neuropsychol Soc; 2021 Oct; 27(9):916-928. PubMed ID: 33342446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.
    Strauss GP; Esfahlani FZ; Kirkpatrick B; Allen DN; Gold JM; Visser KF; Sayama H
    Schizophr Bull; 2019 Oct; 45(6):1319-1330. PubMed ID: 30649527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory Functioning in First-Episode Psychosis.
    Kamath V; Lasutschinkow P; Ishizuka K; Sawa A
    Schizophr Bull; 2018 Apr; 44(3):672-680. PubMed ID: 28981913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.